848439-16-7

Basic information

• Product Name: 16,17-[(cyclohexylmethylene)bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)pregna-1,4-diene-3,20-dione[11beta, 16alpha(R,S)]
• CAS NO: 848439-16-7
• Molecular Weight: 540.697
• Mol File: 848439-16-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 16,17-[(cyclohexylmethylene)bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)pregna-1,4-diene-3,20-dione[11beta, 16alpha(R,S)](CAS DataBase Reference)
• NIST Chemistry Reference: 16,17-[(cyclohexylmethylene)bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)pregna-1,4-diene-3,20-dione[11beta, 16alpha(R,S)](848439-16-7)
• EPA Substance Registry System: 16,17-[(cyclohexylmethylene)bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)pregna-1,4-diene-3,20-dione[11beta, 16alpha(R,S)](848439-16-7)

Safety Data

• Hazardous Substances Data: 848439-16-7(Hazardous Substances Data)

Upstream product

• 97-72-3 2-Methylpropionic anhydride 

Downstream Products

• 204444-45-1 ciclesonide 

Relevant articles and documents

PROCESS FOR PREPARING CRYSTALLINE CICLESONIDE WITH DEFINED PARTICLE SIZE

The invention relates to a novel process for preparing crystalline ciclesonide with an advantageous particle size and to the use for producing pharmaceutical preparations, in particular for topical use. The crystalline ciclesonide obtained by the novel process has advantageous aerodynamic properties, and can be further processed to inhalable or nasally administered pharmaceutical preparations without further mechanical micronization.